GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (XPAR:DIM) » Definitions » Cyclically Adjusted PS Ratio

Sartorius Stedim Biotech (XPAR:DIM) Cyclically Adjusted PS Ratio : 8.87 (As of May. 01, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Sartorius Stedim Biotech Cyclically Adjusted PS Ratio?

As of today (2024-05-01), Sartorius Stedim Biotech's current share price is €203.00. Sartorius Stedim Biotech's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €22.89. Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio for today is 8.87.

The historical rank and industry rank for Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio or its related term are showing as below:

XPAR:DIM' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.44   Med: 12.29   Max: 20.9
Current: 9.1

During the past years, Sartorius Stedim Biotech's highest Cyclically Adjusted PS Ratio was 20.90. The lowest was 7.44. And the median was 12.29.

XPAR:DIM's Cyclically Adjusted PS Ratio is ranked worse than
83.8% of 469 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs XPAR:DIM: 9.10

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted revenue per share data for the three months ended in Dec. 2023 was €7.658. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €22.89 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius Stedim Biotech Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Cyclically Adjusted PS Ratio Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 14.68 10.46

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.68 13.13 10.47 10.16 10.46

Competitive Comparison of Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio falls into.



Sartorius Stedim Biotech Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=203.00/22.89
=8.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sartorius Stedim Biotech's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=7.658/123.6675*123.6675
=7.658

Current CPI (Dec. 2023) = 123.6675.

Sartorius Stedim Biotech Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201012 0.000 94.132 0.000
201106 1.292 95.158 1.679
201112 0.000 95.998 0.000
201206 1.507 96.744 1.926
201212 0.000 97.957 0.000
201306 1.676 98.516 2.104
201312 0.000 99.356 0.000
201406 1.847 99.543 2.295
201412 0.000 99.543 0.000
201506 2.329 100.417 2.868
201512 0.000 99.717 0.000
201606 2.878 100.717 3.534
201612 0.000 101.217 0.000
201706 2.977 102.117 3.605
201709 2.776 102.717 3.342
201712 3.002 102.617 3.618
201803 3.024 102.917 3.634
201806 3.283 104.017 3.903
201809 3.393 104.718 4.007
201812 3.450 104.217 4.094
201903 3.729 104.217 4.425
201906 3.958 105.718 4.630
201909 3.957 106.018 4.616
201912 3.931 105.818 4.594
202003 4.577 105.718 5.354
202006 4.847 106.618 5.622
202009 5.523 105.818 6.455
202012 5.780 105.518 6.774
202103 7.083 107.518 8.147
202106 7.553 108.486 8.610
202109 8.191 109.435 9.256
202112 8.443 110.384 9.459
202203 9.353 113.968 10.149
202206 9.348 115.760 9.987
202209 9.546 118.818 9.936
202212 9.653 119.345 10.003
202303 7.908 122.402 7.990
202306 7.310 123.140 7.341
202309 7.266 124.195 7.235
202312 7.658 123.668 7.658

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius Stedim Biotech  (XPAR:DIM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sartorius Stedim Biotech Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech (XPAR:DIM) Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech (XPAR:DIM) Headlines